207 related articles for article (PubMed ID: 15247426)
1. Functional disassociation of the central and peripheral fatty acid amide signaling systems.
Cravatt BF; Saghatelian A; Hawkins EG; Clement AB; Bracey MH; Lichtman AH
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10821-6. PubMed ID: 15247426
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
3. The enzymatic inactivation of the fatty acid amide class of signaling lipids.
Cravatt BF; Lichtman AH
Chem Phys Lipids; 2002 Dec; 121(1-2):135-48. PubMed ID: 12505696
[TBL] [Abstract][Full Text] [Related]
4. Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.
Pillarisetti S; Alexander CW; Khanna I
Drug Discov Today; 2009 Dec; 14(23-24):1098-111. PubMed ID: 19716430
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of fatty acid amide hydrolase.
McKinney MK; Cravatt BF
Annu Rev Biochem; 2005; 74():411-32. PubMed ID: 15952893
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 5'-sequence of the mouse fatty acid amide hydrolase.
Puffenbarger RA; Kapulina O; Howell JM; Deutsch DG
Neurosci Lett; 2001 Nov; 314(1-2):21-4. PubMed ID: 11698137
[TBL] [Abstract][Full Text] [Related]
7. A FAAH-regulated class of N-acyl taurines that activates TRP ion channels.
Saghatelian A; McKinney MK; Bandell M; Patapoutian A; Cravatt BF
Biochemistry; 2006 Aug; 45(30):9007-15. PubMed ID: 16866345
[TBL] [Abstract][Full Text] [Related]
8. Assignment of endogenous substrates to enzymes by global metabolite profiling.
Saghatelian A; Trauger SA; Want EJ; Hawkins EG; Siuzdak G; Cravatt BF
Biochemistry; 2004 Nov; 43(45):14332-9. PubMed ID: 15533037
[TBL] [Abstract][Full Text] [Related]
9. Progesterone reverts LPS-reduced FAAH activity in murine peripheral blood mononuclear cells by a receptor-mediated fashion.
Wolfson ML; Aisemberg J; Salazar AI; Domínguez Rubio AP; Vercelli CA; Franchi AM
Mol Cell Endocrinol; 2013 Dec; 381(1-2):97-105. PubMed ID: 23906535
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a FAAH variant that discriminates between the N-acyl ethanolamine and taurine families of signaling lipids.
McKinney MK; Cravatt BF
Biochemistry; 2006 Aug; 45(30):9016-22. PubMed ID: 16866346
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
14. Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase.
Blednov YA; Cravatt BF; Boehm SL; Walker D; Harris RA
Neuropsychopharmacology; 2007 Jul; 32(7):1570-82. PubMed ID: 17164820
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
16. Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity.
Mofford DM; Adams ST; Reddy GS; Reddy GR; Miller SC
J Am Chem Soc; 2015 Jul; 137(27):8684-7. PubMed ID: 26120870
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction.
Hedlund P
Neurourol Urodyn; 2014 Jan; 33(1):46-53. PubMed ID: 24285567
[TBL] [Abstract][Full Text] [Related]
18. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
19. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.
Egertová M; Giang DK; Cravatt BF; Elphick MR
Proc Biol Sci; 1998 Nov; 265(1410):2081-5. PubMed ID: 9842734
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis.
Webb M; Luo L; Ma JY; Tham CS
Neurosci Lett; 2008 Jul; 439(1):106-10. PubMed ID: 18501510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
